Antibiotics for amniotic-fluid colonization by Ureaplasma and/or Mycoplasma spp. to prevent preterm birth: A randomized trial
- PMID: 30403730
- PMCID: PMC6221323
- DOI: 10.1371/journal.pone.0206290
Antibiotics for amniotic-fluid colonization by Ureaplasma and/or Mycoplasma spp. to prevent preterm birth: A randomized trial
Abstract
Objective: To assess whether antibiotics used for treatment in asymptomatic second-trimester women positive for Mycoplasma or Ureaplasma spp. detected by amniotic-fluid PCR prevents preterm delivery.
Design: A randomized, double-blind, placebo-controlled trial.
Setting: 10 maternal fetal medicine centers in France.
Population: Women with a singleton pregnancy who underwent amniocentesis between 16 and 20 weeks' gestation (weeks) for Down syndrome screening. A sample of 238 women with PCR-positive findings per treatment group was needed to show a 50% reduction in the preterm delivery rate.
Methods: Amniotic fluid was tested. Women with positive findings on real-time PCR of amniotic fluid for Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Ureaplasma parvum were randomized to receive josamycin or placebo. Amniotic fluid was also tested for 16S PCR.
Main outcome measures: The primary outcome was delivery before 37 weeks.
Results: In total, 1043 women underwent amniotic-fluid screening with specific PCR detection between July 2008 and July 2011: PCR detection failed in 27 (2.6%), and 20 (1.9%) underwent termination of pregnancy. Among the 1016 women with PCR results, 980 had available data for the primary outcome (delivery before 37 weeks) and 29 (3.0%) were positive for Ureaplasma and/or Mycoplasma spp. Because of the low rate of women with PCR-positive findings, the trial was stopped prematurely. In total, 19 women were randomized to receive placebo (n = 8) or josamycin (n = 11) and their characteristics were comparable, as was the rate of preterm delivery and secondary outcomes. In comparing all PCR-positive and -negative women regardless of treatment, PCR positivity for Ureaplasma and/or Mycoplasma spp. was not associated with any adverse pregnancy or neonatal outcome. Amniotic-fluid screening by 16S PCR showed no other bacterial colonization associated with preterm birth.
Conclusions: Because of a low amniotic fluid colonization rate, the trial was interrupted. Maternal amniotic-fluid colonization by Mycoplasma and/or Ureaplasma spp. at 16-20 weeks in asymptomatic women is rare and not associated with adverse pregnancy outcomes.
Trial registration: ClinicalTrials.gov NCT00718705.
Conflict of interest statement
Bayer has provided the treatment (josamycin) only. Bayer did not provide any financial support for the study or to any investigator. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Similar articles
-
Microbial invasion of the amniotic cavity in midtrimester pregnancies using molecular microbiology.Am J Obstet Gynecol. 2017 Jul;217(1):71.e1-71.e5. doi: 10.1016/j.ajog.2017.02.051. Epub 2017 Mar 6. Am J Obstet Gynecol. 2017. PMID: 28268197
-
Second-trimester amniotic fluid proteins changes in subsequent spontaneous preterm birth.Acta Obstet Gynecol Scand. 2023 May;102(5):597-604. doi: 10.1111/aogs.14544. Epub 2023 Mar 14. Acta Obstet Gynecol Scand. 2023. PMID: 36918342 Free PMC article. Clinical Trial.
-
Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome.Am J Obstet Gynecol. 2004 Oct;191(4):1382-6. doi: 10.1016/j.ajog.2004.05.070. Am J Obstet Gynecol. 2004. PMID: 15507969
-
Ureaplasma species and preterm birth: current perspectives.Crit Rev Microbiol. 2020 Mar;46(2):169-181. doi: 10.1080/1040841X.2020.1736986. Epub 2020 Mar 6. Crit Rev Microbiol. 2020. PMID: 32141797 Review.
-
Current understanding and treatment of intra-amniotic infection with Ureaplasma spp.J Obstet Gynaecol Res. 2019 Sep;45(9):1796-1808. doi: 10.1111/jog.14052. Epub 2019 Jul 16. J Obstet Gynaecol Res. 2019. PMID: 31313469 Review.
Cited by
-
Beyond the Gut, Emerging Microbiome Areas of Research: A Focus on Early-Life Microbial Colonization.Microorganisms. 2023 Jan 18;11(2):239. doi: 10.3390/microorganisms11020239. Microorganisms. 2023. PMID: 36838204 Free PMC article. Review.
-
Development of a mouse model of ascending infection and preterm birth.PLoS One. 2021 Dec 2;16(12):e0260370. doi: 10.1371/journal.pone.0260370. eCollection 2021. PLoS One. 2021. PMID: 34855804 Free PMC article.
-
Comparison of Bacterial DNA Profiles in Mid-Trimester Amniotic Fluid Samples From Preterm and Term Deliveries.Front Microbiol. 2020 Mar 24;11:415. doi: 10.3389/fmicb.2020.00415. eCollection 2020. Front Microbiol. 2020. PMID: 32265868 Free PMC article.
-
Mycoplasma genitalium infection in the female reproductive system: Diseases and treatment.Front Microbiol. 2023 Feb 21;14:1098276. doi: 10.3389/fmicb.2023.1098276. eCollection 2023. Front Microbiol. 2023. PMID: 36896431 Free PMC article. Review.
-
Characterisation of Mid-Gestation Amniotic Fluid Cytokine and Bacterial DNA Profiles in Relation to Pregnancy Outcome in a Small Australian Cohort.Microorganisms. 2023 Jun 29;11(7):1698. doi: 10.3390/microorganisms11071698. Microorganisms. 2023. PMID: 37512872 Free PMC article.
References
-
- MacDorman MF, Matthews TJ, Mohangoo AD, Zeitlin J. International comparisons of infant mortality and related factors: United States and Europe, 2010. Natl Vital Stat Rep. 2014;63(5):1–6. Epub 2014/09/25. . - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous